首页> 外文期刊>Thrombosis and Haemostasis: Journal of the International Society on Thrombosis and Haemostasis >Low density lipoprotein receptor-related protein: regulation of the plasma membrane proteome.
【24h】

Low density lipoprotein receptor-related protein: regulation of the plasma membrane proteome.

机译:低密度脂蛋白受体相关蛋白:质膜蛋白质组的调节。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Proteins in the plasma membrane anchor the cell within its microenvironment and sense changes occurring outside the cell. The anchoring interactions are cell type-specific and may involve adjacent cells or extracellular matrix proteins (ECMPs). In development, wound healing, and in various forms of pathology, including thrombosis and atherosclerosis, the microenvironment of the cell may change rapidly and dramatically. How the cell responds is strongly dependent on the protein composition of its plasma membrane, which we refer to as the plasma membrane proteome. Processes that regulate the plasma membrane proteome may alter cellular response. Low density lipoprotein receptor-related protein-1 (LRP-1) is a member of the LDL receptor family; however, LRP-1 and other less well studied members of this gene family demonstrate multiple activities unrelated to lipid homeostasis. LRP-1 binds and internalizes numerous, structurally diverse ligands, delivering most but not all these ligands to lysosomes for degradation. The intracellular tail of LRP-1 binds signaling adaptor proteins and thus may function in cell signaling. Biological activities of LRP-1 include antigen presentation, phagocytosis, removal of apoptotic cells, and regulation of vascular permeability. This review focuses on an emerging view of LRP-1 activity, in which LRP-1 regulates the protein composition of the plasma membrane and thereby "models" or "landscapes" the cell surface. In some cases, plasma membrane modeling results from the binding to bifunctional ligands or intracellular adaptor proteins, so that LRP-1 is bridged to another plasma membrane protein and the entire complex undergoes endocytosis. Membrane proteins already known to be subject to this form of regulation include urokinase-type plasminogen activator receptor, amyloid precursor protein, tissue factor, and alpha(V)-containing integrins. LRP-1 also controls the plasma membrane proteome by regulating maturation and transport of proteins in the secretory pathway. At the same time, LRP-1 serves as a receptor for specific ECMPs, including fibronectin and thrombospondin. Although ECMP-binding to LRP-1 results in endocytosis and catabolism, these receptor-ligation events also may be coupled, directly or indirectly, to cell-signaling. Based on these novel activities, LRP-1 emerges as a protein capable of modeling the interface of the cell with its microenvironment.
机译:质膜中的蛋白质将细胞锚定在其微环境中,并感知细胞外部发生的变化。锚定相互作用是细胞类型特异性的,并且可能涉及邻近细胞或细胞外基质蛋白(ECMP)。在发育,伤口愈合以及各种形式的病理学中,包括血栓形成和动脉粥样硬化,细胞的微环境可能会迅速而剧烈地变化。细胞如何反应在很大程度上取决于其质膜的蛋白质组成,我们将其称为质膜蛋白质组。调节质膜蛋白质组的过程可能会改变细胞反应。低密度脂蛋白受体相关蛋白1(LRP-1)是LDL受体家族的成员。然而,该基因家族的LRP-1和其他研究较少的成员表现出与脂质稳态无关的多种活性。 LRP-1结合并内化许多结构多样的配体,将大多数但不是全部这些配体递送至溶酶体进行降解。 LRP-1的细胞内尾部结合信号转导接头蛋白,因此可能在细胞信号转导中起作用。 LRP-1的生物活性包括抗原呈递,吞噬作用,凋亡细胞的去除和血管通透性的调节。这篇综述着眼于LRP-1活性的新兴观点,其中LRP-1调节质膜的蛋白质组成,从而“模拟”或“修饰”细胞表面。在某些情况下,质膜建模是由与双功能配体或细胞内衔接蛋白的结合产生的,因此LRP-1被桥接到另一种质膜蛋白上,整个复合物都经历了内吞作用。已知会受到这种形式调节的膜蛋白包括尿激酶型纤溶酶原激活剂受体,淀粉样前体蛋白,组织因子和含α(V)的整联蛋白。 LRP-1还通过调节分泌途径中蛋白质的成熟和运输来控制质膜蛋白质组。同时,LRP-1可以作为特定ECMP的受体,包括纤连蛋白和血小板反应蛋白。尽管ECMP与LRP-1结合会导致胞吞作用和分解代谢,但这些受体连接事件也可能直接或间接与细胞信号转导偶联。基于这些新的活动,LRP-1以能够模拟细胞与其微环境的界面的蛋白质形式出现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号